The Recall Desk
CriticalFDA (Drugs)·D-0339-2018·Announced 2018-02-14

Aurobindo Recalls Ampicillin and Sulbactam Injection Due to Glass Particulates

Aurobindo Pharma is recalling 53,040 vials of Ampicillin and Sulbactam for Injection due to a confirmed report of visible glass particulate matter.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The FDA has classified this recall as Class I, which meets the rubric criteria for a Critical severity score.

Plain-English summary

Aurobindo Pharma Ltd. is recalling 53,040 vials of Ampicillin and Sulbactam for Injection, 1.5 g. The product is a sterile dry powder for intramuscular or intravenous injection, distributed nationwide in the USA by AuroMedics Pharma LLC. The specific lot number is AF0117001-A.

The recall was initiated following a confirmed customer report of visible particulate matter within a single vial. The particulate matter was confirmed to be glass. The FDA has classified this recall as Class I, indicating a reasonable probability that use of the product could cause serious adverse health consequences or death.

Healthcare providers and patients should stop using the affected product immediately. Consumers should check their medication for the specific lot number and contact their healthcare provider or pharmacist for instructions on how to return the product or obtain a replacement.

The recalled product

Product
AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM AND SULBACTAM SODIUM)
Brand
AMPICILLIN AND SULBACTAM
Affected units
53,040

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot Number AF0117001-A

UPCs (4)

  • 0355150116201
  • 0355150179992
  • 0355150178995
  • 0355150117208

Distribution

Distributed nationwide across the United States.

Same brand · AMPICILLIN AND SULBACTAM